462 related articles for article (PubMed ID: 28347297)
1. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
Huh H; Lee H; Lee JP; Kim DK; Oh S; Oh YK; Kim YS; Lim CS
BMC Nephrol; 2017 Mar; 18(1):104. PubMed ID: 28347297
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy.
Polanco N; Gutiérrez E; Covarsí A; Ariza F; Carreño A; Vigil A; Baltar J; Fernández-Fresnedo G; Martín C; Pons S; Lorenzo D; Bernis C; Arrizabalaga P; Fernández-Juárez G; Barrio V; Sierra M; Castellanos I; Espinosa M; Rivera F; Oliet A; Fernández-Vega F; Praga M;
J Am Soc Nephrol; 2010 Apr; 21(4):697-704. PubMed ID: 20110379
[TBL] [Abstract][Full Text] [Related]
3. Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study.
Jiang Z; Cai M; Dong B; Yan Y; Wang Y; Li X; Shao C; Zuo L
BMC Nephrol; 2021 Apr; 22(1):148. PubMed ID: 33888083
[TBL] [Abstract][Full Text] [Related]
4. Colquhounia root tablet in the treatment of idiopathic membranous nephropathy with subnephrotic proteinuria.
Xu C; Xu T; Liu N; Liu L; Sun L; Li X; Li Z; Yao L
Int Urol Nephrol; 2024 Feb; 56(2):699-706. PubMed ID: 37480482
[TBL] [Abstract][Full Text] [Related]
5. Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan.
Yamaguchi M; Ando M; Katsuno T; Tsuboi N; Maruyama S
Ren Fail; 2018 Nov; 40(1):435-441. PubMed ID: 30052488
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment.
Polanco N; Gutiérrez E; Rivera F; Castellanos I; Baltar J; Lorenzo D; Praga M;
Nephrol Dial Transplant; 2012 Jan; 27(1):231-4. PubMed ID: 21624942
[TBL] [Abstract][Full Text] [Related]
7. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
[TBL] [Abstract][Full Text] [Related]
8. Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy?
Ponticelli C; Passerini P
J Nephrol; 2010; 23(2):156-63. PubMed ID: 20213607
[TBL] [Abstract][Full Text] [Related]
9. Association of diabetes with failure to achieve complete remission of idiopathic membranous nephropathy.
Xie H; Li C; Wen Y; Ye W; Cai J; Li H; Li X; Li X
Int Urol Nephrol; 2020 Feb; 52(2):337-342. PubMed ID: 31820359
[TBL] [Abstract][Full Text] [Related]
10. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
Hofstra JM; Deegens JK; Willems HL; Wetzels JF
Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
[TBL] [Abstract][Full Text] [Related]
11. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
[TBL] [Abstract][Full Text] [Related]
12. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
[TBL] [Abstract][Full Text] [Related]
13. Acute kidney injury in idiopathic membranous nephropathy with nephrotic syndrome.
Chen T; Zhou Y; Chen X; Chen B; Pan J
Ren Fail; 2021 Dec; 43(1):1004-1011. PubMed ID: 34157952
[TBL] [Abstract][Full Text] [Related]
14. The natural history of the non-nephrotic membranous nephropathy patient.
Hladunewich MA; Troyanov S; Calafati J; Cattran DC;
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1417-22. PubMed ID: 19661220
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of persistent disease and relapse in primary membranous nephropathy.
Kanigicherla DA; Short CD; Roberts SA; Hamilton P; Nikam M; Harris S; Brenchley PE; Venning MC
Nephrol Dial Transplant; 2016 Dec; 31(12):2108-2114. PubMed ID: 26769682
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
[TBL] [Abstract][Full Text] [Related]
17. Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy.
Chen X; Chen Y; Ding X; Zhou Y; Lv Y; Li D; Chen B; Chen T; Chen C
Ren Fail; 2019 Nov; 41(1):363-369. PubMed ID: 31057017
[TBL] [Abstract][Full Text] [Related]
18. Membranous Nephropathy: Quantifying Remission Duration on Outcome.
Cattran DC; Kim ED; Reich H; Hladunewich M; Kim SJ;
J Am Soc Nephrol; 2017 Mar; 28(3):995-1003. PubMed ID: 27756808
[TBL] [Abstract][Full Text] [Related]
19. Remission of proteinuria with treatment of Actinomyces infection: eradicating a cause of secondary membranous glomerulopathy suppresses nephrotic syndrome.
Yoon SY; Lee SC; Park YJ; Rha SH
Nephrol Dial Transplant; 2009 Oct; 24(10):3236-9. PubMed ID: 19515799
[TBL] [Abstract][Full Text] [Related]
20. Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome.
Yuan H; Liu N; Sun GD; Jia Y; Luo P; Miao LN
Pharmacology; 2013; 91(5-6):259-66. PubMed ID: 23652322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]